Novel splicing dysferlin mutation causing myopathy with intra-familial heterogeneity

Mol Biol Rep. 2020 Aug;47(8):5755-5761. doi: 10.1007/s11033-020-05643-9. Epub 2020 Jul 14.

Abstract

Dysferlinopathies belong to the heterogeneous group of autosomal recessive muscular disorders, caused by mutations in the dysferlin gene and characterized by a high degree of clinical variability even though within the same family. This study aims to describe three cases, belonging to a consanguineous Tunisian family, sharing a new splicing mutation in the dysferlin gene and presenting intra-familial variability of dysferlinopathies: Proximal-distal weakness and distal myopathy with anterior tibial onset. We performed the next generation sequencing for mutation screening and reverse transcriptase-PCR for gene expression analysis. Routine muscle histology was used for muscle biopsy processing. The clinical presentation demonstrated heterogeneous phenotypes between the three cases: Two presented intermediate phenotypes of dysferlinopathy with proximal-distal weakness and the third had a distal myopathy with anterior tibial onset. Genetic analysis yielded a homozygous splicing mutation (c.4597-2A>G) in the dysferlin gene, giving rise to the suppression of 28 bp of the exon 43. The splicing mutation found in our family (c.4597-2A>G) is responsible for the suppression of 28 bp of the exon 43 and a wide clinical intra-familial variability.

Keywords: DMAT; DYSF and splicing mutation; Dysferlinopathies; Proximal–distal weakness.

MeSH terms

  • Dysferlin / genetics*
  • Female
  • Genetic Predisposition to Disease
  • High-Throughput Nucleotide Sequencing / methods
  • Humans
  • Male
  • Middle Aged
  • Muscular Diseases / genetics*
  • Muscular Diseases / pathology
  • Muscular Dystrophies, Limb-Girdle / genetics*
  • Muscular Dystrophies, Limb-Girdle / pathology
  • Mutation
  • Phenotype
  • RNA Splicing

Substances

  • DYSF protein, human
  • Dysferlin

Supplementary concepts

  • Dysferlinopathy